Single-Dose Indigenous Liposomal Amphotericin B in the Treatment of Indian Visceral Leishmaniasis: A Phase 2 Study-Reference-Cited by-同舟云学术

Single-Dose Indigenous Liposomal Amphotericin B in the Treatment of Indian Visceral Leishmaniasis: A Phase 2 Study

Published:2015-03-04 Issue:3 Volume:92 Page:513-517
ISSN:0002-9637
Container-title:The American Journal of Tropical Medicine and Hygiene
language:en
Short-container-title:

Author:

Sundar Shyam,Singh Anup,Rai Madhukar,Chakravarty Jaya

Publisher

American Society of Tropical Medicine and Hygiene

Subject

Virology,Infectious Diseases,Parasitology

Reference28 articles.

1. Leishmaniasis worldwide and global estimates of its incidence;Alvar;PLoS ONE,2012

2. Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable;Bhattacharya;Indian J Med Res,2006

3. Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison;Thakur;Bull World Health Organ,1994

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Elimination Status of Visceral Leishmaniasis in Southeast Asia Region;Acta Parasitologica;2024-08-20

2. Host, parasite and drug determinants of clinical outcomes following treatment of visceral leishmaniasis: a protocol for individual participant data meta-analysis;BMJ Open;2023-10

3. Structure-based drug designing against Leishmania donovani using docking and molecular dynamics simulation studies: exploring glutathione synthetase as a drug target;Journal of Biomolecular Structure and Dynamics;2023-07-25

4. Limitations of current chemotherapy and future of nanoformulation-based AmB delivery for visceral leishmaniasis—An updated review;Frontiers in Bioengineering and Biotechnology;2022-12-14

5. Ein Update zur Leishmaniose des Hundes: Diagnostik, Therapie und Monitoring;Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere;2022-12